Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu)

Conclusion: Evocalcet may be a promising therapeutic candidate for symptomatic FHH3.

Saved in:

Bibliographic Details
Main Authors:	Ai Chida, Yutaka Hasegawa, Toshie Segawa, Daisuke Yamabe, Hirotaka Yan, Yusuke Chiba, Hiraku Chiba, Hirofumi Kinno, Tomoyasu Oda, Yoshihiko Takahashi, Koji Nata, Yasushi Ishigaki
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Case Reports in Endocrinology
Online Access:	http://dx.doi.org/10.1155/crie/9514578
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.1155/crie/9514578